NOV vs TECH · P/E 86, rev $8.87B vs P/E 65, rev $1.22B
NOV Inc. (NOV) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
NOV Inc. (NOV) is a oil & gas equipment & services company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported NOV revenue for 2024-12-31 was $8.87B. Net income was $635.0M. Revenue was up 3.3% from 2023-12-31 to 2024-12-31. NOV currently screens at market cap $7.70B and trailing P/E 85.8.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
NOV currently screens at market cap $7.70B and trailing P/E 85.8. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the NOV and TECH stock pages for the full models.
Not investment advice.